Mark Kirschbaum
Nessuna posizione attualmente
Profilo
Mark Kirschbaum held several senior director and director positions in the medical field at Taiho Pharmaceutical Co., Ltd., Nevada Cancer Institute, City of Hope National Cancer Institute, Daiichi Sankyo Ilac Ticaret Ltd.
Sti., and BeiGene USA, Inc. He also served as Vice President of Hematology & Oncology at ArQule, Inc. and as a Professor at The Pennsylvania State University and Monter Cancer Center.
Kirschbaum earned an undergraduate degree from Yeshiva University and a doctorate from State University of New York at Downstate Medical Center.
Precedenti posizioni note di Mark Kirschbaum
| Società | Posizione | Fine |
|---|---|---|
| CYCLACEL PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | 25/01/2024 |
| ARQULE, INC. | Corporate Officer/Principal | 01/10/2020 |
City of Hope National Cancer Institute
 City of Hope National Cancer Institute Hospital/Nursing ManagementHealth Services City of Hope is a research and treatment center for cancer, diabetes and various life-threatening diseases. The center is founded in 1913 and is headquartered in Los Angeles, CA. | Corporate Officer/Principal | - |
| Nevada Cancer Institute | Corporate Officer/Principal | - |
| The Pennsylvania State University | Corporate Officer/Principal | - |
Formazione di Mark Kirschbaum
| Yeshiva University | Undergraduate Degree |
| State University of New York at Downstate Medical Center | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CYCLACEL PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 7 |
|---|---|
ArQule, Inc.
 ArQule, Inc. Pharmaceuticals: MajorHealth Technology ArQule, Inc. is a biopharmaceutical company, which engages in the research and development of therapeutics to treat cancers and rare diseases. The company was founded in 1993 and is headquartered in Burlington, MA. | Health Technology |
Taiho Pharmaceutical Co., Ltd.
 Taiho Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Taiho Pharmaceutical Co., Ltd. engages in the production of drugs and medical products. It researches, innovates, and develops pharmaceuticals for various diseases. The company was founded on June 1, 1963 and is headquartered in Tokyo, Japan. | Health Technology |
| Nevada Cancer Institute | Health Services |
City of Hope National Cancer Institute
City of Hope National Cancer Institute Hospital/Nursing ManagementHealth Services City of Hope is a research and treatment center for cancer, diabetes and various life-threatening diseases. The center is founded in 1913 and is headquartered in Los Angeles, CA. | Health Services |
Daiichi Sankyo Ilac Ticaret Ltd. Sti.
 Daiichi Sankyo Ilac Ticaret Ltd. Sti. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo Ilaç Ticaret Ltd Sti engages in the production and distribution of medical preparations of the brand Daiichi Sankyo in Turkey. It specializes on such illnesses, as hypertension, osteoporosis, deep venous thrombosis, and heart diseases. The company was founded on September 28, 2005 and is headquartered in Istanbul, Turkey. | Health Technology |
BeiGene USA, Inc.
 BeiGene USA, Inc. Pharmaceuticals: MajorHealth Technology BeiGene USA, Inc. engages in pharmaceutical development. The company is headquartered in Cambridge, MA. | Health Technology |
| Monter Cancer Center |
- Borsa valori
- Insiders
- Mark Kirschbaum
